Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis

Objective To examine the performance in adults of the European Alliance of Associations for Rheumatology (EULAR)/Pediatric Rheumatology European Society (PReS)-endorsed Ankara 2008 classification criteria for IgA vasculitis (IgAV).Methods The EULAR/PReS/Ankara 2008 classification criteria for IgAV w...

Full description

Saved in:
Bibliographic Details
Main Authors: Ömer Karadağ, Seza Ozen, Cristina Ponte, Richard A Watts, Raashid Ahmed Luqmani, Peter C Grayson, Peter A Merkel, Ravi Suppiah, Joanna C Robson, Alexandra Audemard-Verger, Selcan Demir, Cemal Bes, Yagmur Bayindir, Katherine B Gribbons, Bugu Bulat, Fatih Yildirim
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/11/3/e005728.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850072584753774592
author Ömer Karadağ
Seza Ozen
Cristina Ponte
Richard A Watts
Raashid Ahmed Luqmani
Peter C Grayson
Peter A Merkel
Ravi Suppiah
Joanna C Robson
Alexandra Audemard-Verger
Selcan Demir
Cemal Bes
Yagmur Bayindir
Katherine B Gribbons
Bugu Bulat
Fatih Yildirim
author_facet Ömer Karadağ
Seza Ozen
Cristina Ponte
Richard A Watts
Raashid Ahmed Luqmani
Peter C Grayson
Peter A Merkel
Ravi Suppiah
Joanna C Robson
Alexandra Audemard-Verger
Selcan Demir
Cemal Bes
Yagmur Bayindir
Katherine B Gribbons
Bugu Bulat
Fatih Yildirim
author_sort Ömer Karadağ
collection DOAJ
description Objective To examine the performance in adults of the European Alliance of Associations for Rheumatology (EULAR)/Pediatric Rheumatology European Society (PReS)-endorsed Ankara 2008 classification criteria for IgA vasculitis (IgAV).Methods The EULAR/PReS/Ankara 2008 classification criteria for IgAV were applied to patients enrolled in an international observational cohort which included patients with IgAV and comparators with other forms of small-vessel and medium-vessel vasculitis. After the initial assessment of the performance of the criteria, possible revisions to increase the performance were tested. The revised criteria were then assessed in an independent validation cohort within a multicentre Turkish vasculitis registry.Results The dataset consisted of 178 IgAV cases and 1705 comparators. The Ankara 2008 criteria require skin involvement plus one of the following four criteria: abdominal pain, a biopsy showing IgA deposition, arthritis or arthralgia, or renal involvement (any haematuria and/or proteinuria). The specificity of the criteria improved when a positive test for anti-neutrophil cytoplasmic autoantibody or blood cryoglobulins was considered an exclusion criterion. The revised criteria had a sensitivity of 76.4% (95% CI 69.8% to 82.2%) and a specificity of 94.5% (95.0% CI 93.4% to 95.1%). In the validation set, the sensitivity and specificity of the revised criteria were 97.8% (95% CI 94.0% to 99.0%) and 85.0% (95.0% CI 78.0% to 90.0%), respectively.Conclusion The revised EULAR/PReS-endorsed Ankara 2008 IgAV classification criteria perform well in adults with IgAV and are appropriate for use in clinical research.
format Article
id doaj-art-4e9eb522e79c4199b3215d6b00c1f963
institution DOAJ
issn 2056-5933
language English
publishDate 2025-07-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj-art-4e9eb522e79c4199b3215d6b00c1f9632025-08-20T02:47:03ZengBMJ Publishing GroupRMD Open2056-59332025-07-0111310.1136/rmdopen-2025-005728Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitisÖmer Karadağ0Seza Ozen1Cristina Ponte2Richard A Watts3Raashid Ahmed Luqmani4Peter C Grayson5Peter A Merkel6Ravi Suppiah7Joanna C Robson8Alexandra Audemard-Verger9Selcan Demir10Cemal Bes11Yagmur Bayindir12Katherine B Gribbons13Bugu Bulat14Fatih Yildirim15Department of Rheumatology, Hacettepe University, Ankara, TurkeyDepartment of Pediatric Rheumatology, Hacettepe University, Ankara, TurkeyRheumatology Department, Unidade Local de Saúde Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, PortugalUniversity of East Anglia, Norwich, UKUniversity of Oxford, Oxford, UKNational Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USAUniversity of Pennsylvania, Philadelphia, Pennsylvania, USAAuckland District Health Board, Auckland, New ZealandUniversity of the West of England, Bristol, UKCentre Hospitalier Régional Universitaire de Tours, Tours, FranceDepartment of Pediatric Rheumatology, Eskisehir Osmangazi University, Eskisehir, TurkeyBaşakşehir Çam Sakura City Hospital, Department of Rheumatology, Istanbul, TurkeyDepartment of Pediatric Rheumatology, Hacettepe University, Ankara, TurkeyBrigham and Women’s Hospital, Boston, Massachusetts, USADepartment of Rheumatology, Hacettepe University, Ankara, TurkeyBaşakşehir Çam Sakura City Hospital, Department of Rheumatology, Istanbul, TurkeyObjective To examine the performance in adults of the European Alliance of Associations for Rheumatology (EULAR)/Pediatric Rheumatology European Society (PReS)-endorsed Ankara 2008 classification criteria for IgA vasculitis (IgAV).Methods The EULAR/PReS/Ankara 2008 classification criteria for IgAV were applied to patients enrolled in an international observational cohort which included patients with IgAV and comparators with other forms of small-vessel and medium-vessel vasculitis. After the initial assessment of the performance of the criteria, possible revisions to increase the performance were tested. The revised criteria were then assessed in an independent validation cohort within a multicentre Turkish vasculitis registry.Results The dataset consisted of 178 IgAV cases and 1705 comparators. The Ankara 2008 criteria require skin involvement plus one of the following four criteria: abdominal pain, a biopsy showing IgA deposition, arthritis or arthralgia, or renal involvement (any haematuria and/or proteinuria). The specificity of the criteria improved when a positive test for anti-neutrophil cytoplasmic autoantibody or blood cryoglobulins was considered an exclusion criterion. The revised criteria had a sensitivity of 76.4% (95% CI 69.8% to 82.2%) and a specificity of 94.5% (95.0% CI 93.4% to 95.1%). In the validation set, the sensitivity and specificity of the revised criteria were 97.8% (95% CI 94.0% to 99.0%) and 85.0% (95.0% CI 78.0% to 90.0%), respectively.Conclusion The revised EULAR/PReS-endorsed Ankara 2008 IgAV classification criteria perform well in adults with IgAV and are appropriate for use in clinical research.https://rmdopen.bmj.com/content/11/3/e005728.full
spellingShingle Ömer Karadağ
Seza Ozen
Cristina Ponte
Richard A Watts
Raashid Ahmed Luqmani
Peter C Grayson
Peter A Merkel
Ravi Suppiah
Joanna C Robson
Alexandra Audemard-Verger
Selcan Demir
Cemal Bes
Yagmur Bayindir
Katherine B Gribbons
Bugu Bulat
Fatih Yildirim
Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis
RMD Open
title Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis
title_full Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis
title_fullStr Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis
title_full_unstemmed Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis
title_short Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis
title_sort performance in adults of the eular printo pres ankara 2008 classification criteria for iga vasculitis
url https://rmdopen.bmj.com/content/11/3/e005728.full
work_keys_str_mv AT omerkaradag performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT sezaozen performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT cristinaponte performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT richardawatts performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT raashidahmedluqmani performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT petercgrayson performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT peteramerkel performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT ravisuppiah performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT joannacrobson performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT alexandraaudemardverger performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT selcandemir performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT cemalbes performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT yagmurbayindir performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT katherinebgribbons performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT bugubulat performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis
AT fatihyildirim performanceinadultsoftheeularprintopresankara2008classificationcriteriaforigavasculitis